Effects of morphine administration on cerebellar guanosine 3',5'-monophosphate
- PMID: 11121
- DOI: 10.1007/BF01937430
Effects of morphine administration on cerebellar guanosine 3',5'-monophosphate
Abstract
An increase in mouse cerebellar C-GMP levels during acute morphine treatment was observed, which was possibly related to the decrease in C-GMP phosphodiesterase levels also observed in acute treatment. Chronic treatment lowered C-GMP levels as did abrupt withdrawal without naloxone.
Similar articles
-
[Modulation of cGMP levels, soluble guanylate cyclase and phosphodiesterase activities in brain of morphine-dependent mice].Yao Xue Xue Bao. 1998 Dec;33(12):896-900. Yao Xue Xue Bao. 1998. PMID: 12016853 Chinese.
-
Effect of acute morphine administration on the cerebellar cyclic GMP level in two strains of mice.Commun Psychopharmacol. 1978;2(2):85-91. Commun Psychopharmacol. 1978. PMID: 27330 No abstract available.
-
Morphine reduces cerebellar guanosine-3',5'-cyclic monophosphate content and elevates cerebrospinal fluid guanosine-3',5'-cyclic monophosphate content in rhesus monkey.Life Sci. 1978 Feb;22(6):467-72. doi: 10.1016/0024-3205(78)90426-5. Life Sci. 1978. PMID: 203814 No abstract available.
-
Signal transduction: activation of the guanylate cyclase-cyclic guanosine-3'-5' monophosphate system by hormones and free radicals.Am J Med Sci. 1997 Nov;314(5):311-23. doi: 10.1097/00000441-199711000-00008. Am J Med Sci. 1997. PMID: 9365333 Review.
-
Cyclic GMP.Adv Cyclic Nucleotide Res. 1973;3:155-223. Adv Cyclic Nucleotide Res. 1973. PMID: 4150323 Review. No abstract available.